Exelixis Inc
EXEL
Company Profile
Business description
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Contact
1851 Harbor Bay Parkway
Alameda CA 94502
USAT: +1 650 837-7000
E: shubbard@exelixis.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
1,310
Exelixis Inc News & Analysis
stocks
9 mid-cap stocks for your US pick list
Clothing retailer Gap, brewer Molson Coors and Exelixis, which develops kidney and liver cancer treatments, are among recent additions to Morningstar's list of mid-sized US companies trading at attractive prices.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,900.30 | 50.90 | 0.65% |
| CAC 40 | 7,914.65 | 70.28 | -0.88% |
| DAX 40 | 17,896.50 | 35.67 | -0.20% |
| Dow JONES (US) | 38,225.66 | 322.37 | 0.85% |
| FTSE 100 | 8,172.15 | 50.91 | 0.63% |
| HKSE | 18,413.79 | 206.66 | 1.14% |
| NASDAQ | 15,840.96 | 235.48 | 1.51% |
| Nikkei 225 | 38,236.07 | 37.98 | -0.10% |
| NZX 50 Index | 11,910.43 | 36.39 | 0.31% |
| S&P 500 | 5,064.20 | 45.81 | 0.91% |
| S&P/ASX 200 | 7,631.70 | 44.70 | 0.59% |
| SSE Composite Index | 3,104.82 | 8.22 | -0.26% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Red 5 Ltd RED | 0.43 | 0.01 | -1.16% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 1.56% |
| Telstra Group Ltd TLS | 3.58 | 0.01 | -0.28% |
| Pilbara Minerals Ltd PLS | 4.19 | 0.13 | 3.20% |
| Capitol Health Ltd CAJ | 0.25 | 0.01 | 2.08% |
| South32 Ltd S32 | 3.60 | 0.05 | 1.41% |
| The Star Entertainment Group Ltd SGR | 0.43 | 0.02 | 4.27% |
| Evolution Mining Ltd EVN | 3.77 | 0.18 | -4.56% |
| Imugene Ltd IMU | 0.08 | 0.00 | -2.35% |
| Zip Co Ltd ZIP | 1.30 | 0.06 | 4.44% |